Let’s take a trip back in time to the year 2001:
- A new president is sworn into office;
- the Global War on Terror begins;
- and a discovery is made on the effects of an alteration to a gene.
(Source: Shutterstock)
According to the Mediators of Inflammation journal, this gene, called NLRP3, is altered in at least 60% of patients who have what is known as cryopyrin associated periodic syndrome (CAPS), a family of inherited inflammatory diseases such as Muckle-Wells Disease, Familial Cold Autoinflammatory Syndrome (FCAS) , and Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
These CAPS patients aren’t the only ones affected by mutations in NLRP3.
Who else is affected?
Click here to read more about how the NLRP3 gene mutation plays a role in Inflammatory Bowel Disease, cardiovascular disease, rheumatoid arthritis, ankylosing spondylitis, celiac disease and more.
